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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 74, Revision 3 
(FGE.74Rev3): Consideration of Simple Aliphatic Sulphides and Thiols 
evaluated by the JECFA (53rd and 61st meeting) Structurally related to 
Aliphatic and Alicyclic Mono-, Di-, Tri-, and Polysulphides with or without 
Additional Oxygenated Functional Groups from Chemical Group 20 
evaluated by EFSA in FGE.08Rev5 (2012)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to consider evaluations of flavouring substances assessed since 2000 by the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide whether further evaluation is 
necessary, as laid down in Commission Regulation (EC) No 1565/2000. The present consideration concerns a 
group of 19 simple aliphatic sulphides and thiols evaluated by the JECFA at the 53rd meeting in 1999 and the 61st 
meeting in 2003. The substances were evaluated through a stepwise approach that integrates information on 
structure-activity relationships, intake from current uses, toxicological threshold of concern, and available data 
on metabolism and toxicity. For nine substances [FL-no: 12.088, 12.179, 12.198, 12.212, 12.238, 12.239, 
12.255, 12.257 and 12.291] considered in this FGE, the Panel concluded that they would pose “No safety 
concern at estimated levels of intake as flavouring substances” based on the MSDI approach. Besides the safety 
assessment of these flavouring substances, the specifications for the materials of commerce have also been 
considered for the substances evaluated through the Procedure and for all nine substances, the information is 
adequate. Thus, the Panel concluded that nine substances [FL-no: 12.088, 12.179, 12.198, 12.212, 12.238, 
12.239, 12.255, 12.257 and 12.291] do not give rise to safety concern at their levels of dietary intake, estimated 
on the basis of the MSDI approach. For 10 candidate substances in FGE.74Rev3 [FL-no: 12.009, 12.013, 12.020, 
12.023, 12.045, 12.074, 12.155, 12.169, 12.241 and 12.280] evaluated through the Procedure, the Panel 
concluded that additional toxicity data are required. 
© European Food Safety Authority, 2014 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion to 
the Commission on the implications for human health of chemically defined flavouring substances 
used in or on foodstuffs in the Member States. In particular, the CEF Panel was requested to consider 
the Joint FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring 
substances assessed since 2000, and to decide whether no further evaluation is necessary, as laid down 
in Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
The JECFA has evaluated a group of 12 simple aliphatic sulphides and thiols at the 61st meeting and 
seven trisulphides and one monosulphide in a group of simple aliphatic and aromatic sulphides and 
thiols at the 53rd meeting. One of the substances evaluated by the JECFA at its 61st meeting is not in 
the Register (spiro[2,4-dithia-1-methyl-8-oxabicyclo(3.3.0)octane-3,3'-(1'-oxa-2'-methyl)-cyclo-
pentane], JECFA-no: 1296). Accordingly, this consideration will deal with 19 JECFA evaluated 
substances. 
This revision is made due to additional genotoxicity data have been submitted for 4-mercapto-4-
methyl-2-pentanone [FL-no: 12.169]. In addition, for seven substances [FL-no: 12.009, 12.020, 
12.045, 12.169, 12.238, 12.239 and 12.291] new data on specifications have been included. Industry 
also submitted additional information intended to support the derivation of a NOAEL for substances in 
subgroup VI (tri- and poly-sulphides). 
The Panel concluded that the 19 substances in the JECFA flavouring group of simple aliphatic 
sulphides and thiols are structurally related to the group of aliphatic and alicyclic mono-, di-, and 
polysulphides with or without additional oxygenated functional groups evaluated by EFSA in the 
Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5).  
The results of the additional genotoxicity study on [FL no: 12.169] alleviate the concern for 
genotoxicity of two substances [FL no: 12.169 and 12.241] and therefore these two substances can be 
evaluated through the Procedure. For the remaining 17 substances in FGE.74Rev2 the Panel 
considered already before, that the genotoxicity data available do not preclude evaluating these 
substances through the Procedure. 
The Panel agrees with the application of the Procedure as performed by the JECFA for five of the 19 
aliphatic sulphides and thiols [FL-no: 12.238, 12.239, 12.255, 12.257 and 12.291], and concluded, 
similar the JECFA that these would not a pose safety concern at the current levels of exposure based 
on the MSDI approach. For three substances [FL- no: 12.179, 12.198 and 12.212] the Panel reached 
the same conclusion, but used a NOAEL from a different study as the one used by the JECFA. 
For diallyl sulphide [FL-no: 12.088] the JECFA evaluated this substance at step B5 to be of no safety 
concern as the estimated intake in the USA is 0.4 µg/capita/day, which is below 1.5 µg/day. The Panel 
does not make use of this threshold of 1.5 µg per person per day. However, the Panel decided that this 
substance could be allocated to subgroup I, for which a supporting substance [FL-no: 12.006] provides 
a NOAEL. Based on the intake estimate (MSDI) for diallyl sulphide [FL-no: 12.088] and this NOAEL 
an adequate margin of safety of 4.3 x 106 could be calculated. 
For the two tertiary thiols [FL-no: 12.169 and 12.241] the Panel did not agree with the JECFA that 
appropriate studies were available for deriving NOAELs, and accordingly the Panel concluded that 
additional data are required for these two substances. 
For the eight tri- and polysulphides [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074, 12.155 
and 12.280], the Panel concluded that the additional information submitted by the Industry was 
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insufficient to evaluate the safety of the tri- and polysulphides. Therefore there is still a need for a 90-
day study for these substances. 
For one substance use levels have been provided by the Industry. The mTAMDI figure calculated for 
the substances [FL-no: 12.291] is below the threshold of concern for structural class I. For the 
remaining 18 substances use levels must be provided. These are needed to calculate the mTAMDIs in 
order to identify those flavouring substances that need a more refined exposure assessment and to 
finalise the evaluation. 
In order to determine whether the conclusion for the JECFA evaluated substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Specifications including 
purity criteria and identity are available for all the JECFA evaluated substances.  
Thus, for 10 candidate substances in FGE.74Rev3 [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 
12.074, 12.155, 12.169, 12.241 and 12.280] evaluated through the Procedure, the Panel concluded that 
additional toxicity data are required. 
For the remaining nine JECFA evaluated simple aliphatic sulphides and thiols [FL-no: 12.088, 12.179, 
12.198, 12.212, 12.238, 12.239, 12.255, 12.257 and 12.291] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 20084 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/20125. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/20006. 
On 24 November 2011, the EFSA Panel on Food Contact Material, Enzymes, Flavouring and 
Processing Aids (CEF) adopted an opinion on FGE.74 Revision 2: consideration of simple aliphatic 
sulphides and thiols evaluated by the JECFA (53rd and 61st meeting) structurally related to aliphatic 
and alicyclic mono-, di-, tri- and polysulphides with and without additional oxygenated functional 
groups from chemical group 20 evaluated by EFSA in FGE.08 Rev3 (2011). 
In this opinion EFSA has considered the Joint FAO/WHO Expert Committee on Food Additives (the 
JECFA) evaluation of 19 simple aliphatic sulphides and thiols with and without an additional 
oxygenated functional group evaluated in the flavouring group evaluation 74 (FGE.74) and its latest 
revision. EFSA concluded in its opinion, contrary to the JECFA, that the two tertiary thiols [FL-no: 
12.169 and 12.241] should not be evaluated using the Procedure due to the concern for genotoxicity 
and , therefore, additional data was requested.  
In addition, in the same opinion, for eight tri- and polysulphides [FL-no: 12.009, 12.013, 12.020, 
12.023, 12.045, 12.074, 12.155 and 12.280], the Panel did not agree with the JECFA that appropiate 
studies were available for deriving NOAELs, and accordingly additional data are required for these 
eight substances. For two of these substances [FL-no: 12.045 and 12.155] the JECFA evaluation is 
only based on MSDI values derived from production figures from the USA. EU production figures are 
needed in order to finalise the evaluation of these substances. 
Subsequently, these substances were included in the Union List with a Footnote 1, 2 or 4. 
The requested information on the representative material, 2-methyl-4-oxopentane-2-thiol [FL-no: 
12.169], was submitted by the European Flavour Association and forwarded by the Commission to 
EFSA on 26 April 2013. This information is intended to cover the re-evaluation of this substance and 
of 2-mercapto-2-methylpentan-1-ol [FL-no: 12.241] from FGE.74.  
On 8 and 11 July 2013, the applicant submitted additional relevant data on these polysulphydes, 
represented by methyl propyl trisulfide [FL-no: 12.020]. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new 
information and, depending on the outcome, proceed to the full evaluation on these flavouring 
substances in accordance with Commission Regulation (EC) N° 1565/2000. 
 
                                                     
4  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and 
certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 
1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34-50. 
5  Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances 
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to 
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) 
No 1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p, 1-161. 
6  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8-16. 
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ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the “EFSA Procedure”. This Procedure 
is based on the Opinion of the Scientific Committee on Food (SCF, 1999), which has been derived 
from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999a), hereafter named the “JECFA 
Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be evaluated through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the Maximised Survey-derived Daily Intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified Theoretical Added Maximum Daily Intake 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram (µg)/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
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Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 µg per person per 
day would not be expected to present a safety concern. The Committee recommended that the 
Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be amended 
to include the last step on the right-hand side of the original procedure (“Do the condition of use result 
in an intake greater than 1.5 µg per day?”)” (JECFA, 1999a).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 µg per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro, 
will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
1. History of the Evaluation of the Substances in the Present FGE  
At its 61st meeting the JECFA evaluated a group of 12 flavouring substances consisting of simple 
aliphatic sulphides and thiols. One substance was not in the Register. The remaining 11 flavouring 
substances have originally been considered by EFSA in the FGE.74 (EFSA, 2008). The Panel 
concluded that for two substances [FL-no: 12.169 and 12.241], the Procedure should not be applied 
until adequate genotoxicity data become available and for three substances [FL-no: 12.179, 12.198 
and 12.212] additional toxicity data were required. 
In the first revision of Flavouring Group Evaluation 74 (FGE.74Rev1) there was a reassessment of 
four candidate substances due to sub-grouping of the substances based on the type of sulphur-
containing functional groups. This is in accordance with what has been done in FGE.08Rev1 (EFSA 
CEF Panel, 2010a) and in FGE.91 (EFSA CEF Panel, 2010b), which also consider substances with 
sulphur-containing functional groups. The candidate substances in FGE.74Rev1 that have been 
reassessed due to this are [FL-no: 12.179, 12.198, 12.212 and 12.280]. The outcome of the evaluation 
is explained in Section 6.3. Furthermore, the FGE.74Rev1 included the assessment of seven additional 
substances [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074 and 12.155] evaluated by the 
JECFA at the 53rd meeting in 1999. The reason for the inclusion of these seven substances is explained 
in Section 2.1.2. 
In the second revision of FGE.74, FGE.74Rev2, one candidate substance has been added, diallyl 
sulphide [FL-no: 12.088]. This substance has been evaluated by the JECFA at the 53rd meeting in 
1999. The reason for the inclusion of this substance is explained in Section 2.1.2. For four substances 
[FL-no: 12.009, 12.020, 12.045 and 12.169] additional information on specifications received after 
publication of FGE.74Rev1 has been included. 
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FGE Opinion adopted Link No. of substances 
FGE.74 January 2008 http://www.efsa.europa.eu/en/efsajournal/pub/987.htm 11 
FGE.74Rev1 September 2010 http://www.efsa.europa.eu/en/efsajournal/pub/1842.htm 18 
FGE.74Rev2 November 2011 http://www.efsa.europa.eu/en/efsajournal/pub/2458.htm 19 
FGE.74Rev3   19 
 
The present revision of FGE.74 (FGE.74Rev3) concerns the re-consideration of two JECFA-evaluated 
substances [FL-no: 12.169 and 12.241]. For these two substances, the Panel concluded previously 
(FGE.74) that the Procedure should not be applied until adequate genotoxicity data would be 
available. 
For 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] additional genotoxicity data (bacterial reverse 
mutation assay) have been submitted (Mc Garry, 2012). This substance [FL-no: 12.169] from 
FGE.74Rev3 is considered a representative for tertiary monothiols in the Union List, i.e. [FL-no: 
12.241] in this FGE, [FL-no: 12.304] in FGE.08Rev5 and [FL-no: 12.038, 12.085, 12.137, 12.138, 
12.145, 12.252 and 12.259] in FGE.91. 
Additional data for the tri- and polysulphides have been submitted by the Industry (IOFI, 2013). The 
data include argument for “structure activity relationship” between disulphides and trisulphides, a 90-
day inhalation study on dimethyl disulphide and two 90-day studies by Morgareidge and Oser 
(Morgareidge and Oser, 1970a; Morgareidge and Oser, 1970b).  
Since the publication of FGE.74Rev2, information on European production figures has been provided 
by EFFA for four substances: [FL-no: 12.045, 12.155, 12.169 and 12.241] (IOFI, 2012; EFFA, 2013). 
For four substances [FL-no: 12.009, 12.020, 12.045 and 12.169] information has been provided and 
for three substances [12.238, 12.239 and 12.291] additional information on stereoisomerism has been 
submitted (EFFA, 2013; EFFA, 2014). These data are also included in the present revision. 
2. Presentation of the Substances in the JECFA Flavouring Group 
2.1. Description 
2.1.1. JECFA Status 
The JECFA has evaluated a group of 12 flavouring substances consisting of simple aliphatic sulphides 
and thiols at the 61st meeting (JECFA, 2004a; JECFA, 2004b).  
The JECFA has at the 53rd meeting (JECFA, 2000), before 2000, evaluated a group of 137 flavouring 
substances consisting of simple aliphatic and aromatic sulphides and thiols with and without an 
additional oxygenated functional group. 
2.1.2. EFSA Considerations 
This FGE deals with 19 JECFA evaluated substances. Eleven substances from the 61st meeting, 2003, 
and eight substances from the 53rd meeting, 1999, because: 
• Of the 12 simple aliphatic sulphides and thiols evaluated by the JECFA at the 61st meeting one is 
not in the Register (spiro[2,4-dithia-1-methyl-8-oxabicyclo(3.3.0)octane-3,3'-(1'-oxa-2'-methyl)-
cyclopentane], JECFA-no: 1296). From the 61st JECFA meeting, 11 substances remain to be 
evaluated by EFSA. 
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• Of the 137 simple aliphatic and aromatic sulphides and thiols with and without an additional 
oxygenated functional group evaluated by the JECFA at the 53rd meeting, seven are acyclic 
polysulphides [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074 and 12.155]. These seven 
substances were evaluated by the JECFA before the year 2000 and have been used as supporting 
substances in FGE.08 and following revisions. For flavouring substances evaluated by the JECFA 
before 2000 it is laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000) that if they 
are considered acceptable at the current estimated intake by the JECFA and comply with the 
general use criteria, they could be included in the list of authorised substances without undergoing 
a separate evaluation for the time being. In the FGE.08Rev1 (EFSA CEF Panel, 2010a), it was 
recognised that tri- and polysulphides may form reactive metabolites and accordingly in 
FGE.74Rev1, the Panel decided to reconsider these seven polysulphides previously evaluated by 
the JECFA (see Comment on Subgroup VI (Acyclic tri- and polysulphides), below). Further, for 
diallyl sulphide [FL-no: 12.088], which the JECFA evaluated at step B5, no NOAEL exists to 
provide a margin of safety. However, as the estimated intake in the USA of 0.4 µg/capita/day is 
below the threshold of concern of 1.5 µg/person/day the JECFA Committee noted that intakes 
below this value would not be expected to present a safety concern. In line with the opinion 
expressed by the Scientific Committee on Food (SCF, 1999), the Panel does not make use of this 
threshold of 1.5 µg/person/day. From the 53rd JECFA meeting eight substances remain to be 
evaluated by EFSA. In addition, in FGE.08Rev1 the genotoxicity issues that were noted for 
candidate tertiary thiols are obviously also of relevance for two candidate JECFA-evaluated 
tertiary thiols [FL nos: 12.169 and 12.241] in this consideration. 
The Panel concluded that the substances in the JECFA flavouring group of simple aliphatic sulphides 
and thiols are structurally related to the group of aliphatic and alicyclic mono-, di-, tri-, and 
polysulphides with or without additional oxygenated functional groups evaluated by EFSA in the 
Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5). Depending on the type of sulphur-
containing functional groups, the substances in FGE.08Rev5 were subdivided into 11 subgroups:  
I Acyclic sulphides 
II Cyclic sulphides 
III Monothiols, including tertiary monothiols 
IV Dithiols 
V Acyclic and cyclic disulphides 
VI Acyclic polysulphides 
VII Mono-, di-, tri- and polysulphides with thioacetal structure 
VIII Thioesters 
IX Thioic acid 
X Sulphoxides/sulphones and sulphonates 
XI Cyclic thioketal fused with an oxolane ring.  
In the following part of this third revision of FGE.74 (FGE.74Rev3) there will be reference to the 
revision 5 of FGE.08 (FGE.08Rev5) (EFSA CEF Panel, 2012b). It is also revision 5 of FGE.08 that is 
used in the application of the Procedure by EFSA (Section 5.2 of this FGE.74Rev3).  
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The 19 JECFA evaluated substances in the present FGE will be considered in compliance with these 
EFSA defined subgroups. 
Comment on Subgroup VI (Acyclic tri- and polysulphides) 
During the evaluation of the candidate substances in the FGE.08Rev1 (EFSA CEF Panel, 2010a), it 
was recognised that tri- and polysulphides (subgroup VI) may form reactive metabolites through 
reaction with endogenous thiols forming a thiol and a hydropersulphide or perthiol. Compared to 
thiols, perthiols may be strong reducing agents, forming reactive products when exposed to oxidants. 
Based on the above information it was concluded that tri- and polysulphides could not be covered by 
No Observed Adverse Effect Levels (NOAELs) for disulphides, due to the formation of more reactive 
metabolites. 
The Panel noted that in FGE.08Rev1 seven supporting substances are tri- or polysulphides [FL-no: 
12.009, 12.013, 12.020, 12.023, 12.045, 12.074 and 12.155]. These substances were evaluated by 
JECFA before the year 20007 (accepted at step B4 based on NOAELs derived from studies with 
disulphides), and therefore at first not included in the consideration performed by EFSA on the JECFA 
evaluated substances in FGE.74. 
Accordingly, the decision taken in FGE.08Rev1 has had an impact on the tri- and polysulphides in 
FGE.74 (one substance [FL-no: 12.280]) as well as those evaluated by the JECFA at its 53rd meeting, 
before 2000 (seven substances [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074 and 12.155]), 
which were therefore included in the first revision of FGE.74 (FGE.74Rev1) (EFSA CEF Panel, 
2010c). 
Distribution of the FGE.74Rev3 substances into subgroups 
The 19 JECFA evaluated substances in this FGE have been assigned to five subgroups, in accordance 
with the subdivision in FGE.08Rev5. This subdivision is shown in Table 1 below.  
Table 1:  Allocation of the 19 JECFA evaluated Substances into Subgroups according to 
Subdivision in FGE.08Rev5 
FL-no:  Register name Structural formula 
I Acyclic sulphides 
12.088 Diallyl sulphide S  
12.179 2-(Methylthio)ethan-1-ol HO
S
 
12.212 Ethyl-5-(methylthio)valerate 
O
O S  
III Monothiols 
12.169 2-Methyl-4-oxopentane-2-thiol 
SH
O
12.238 3-Mercapto-2-methylpentan-1-ol OH
SH
                                                     
7  For flavouring substances evaluated by the JECFA before 2000 it is laid down in Commission Regulation (EC) 1565/2000 
(EC, 2000a) that if they are considered acceptable at the current estimated intake by the JECFA and comply with the 
general use criteria, they could be included in the list of authorised substances without undergoing a separate evaluation for 
the time being. 
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Table 1:  Allocation of the 19 JECFA evaluated Substances into Subgroups according to 
Subdivision in FGE.08Rev5 
FL-no:  Register name Structural formula 
12.239 3-Mercapto-2-methylpentanal 
O
HS
12.241 2-Mercapto-2-methylpentan-1-ol HO
SH
12.255 Ethyl 3-mercaptobutyrate 
O
O SH
12.291 3-Mercapto-2-methyl-1-butanol OH
SH
V Acyclic and cyclic disulphides 
12.198 2,3,5-Trithiahexane S S S  
VI Acyclic tri- and polysulphides 
12.009 Diallyl trisulfide S S
S
 
12.013 Dimethyl trisulfide S S
S
12.020 Methyl propyl trisulfide S
SS
 
12.023 Dipropyl trisulfide S S
S
 
12.045 Methyl allyl trisulfide S
SS
 
12.074 Diallyl polysulfides 
SX
X=2,3,4 or 5  
12.155 Methyl ethyl trisulfide S
S S
 
12.280 Diisopropyl trisulphide 
S
S
S
VIII Thioesters 
12.257 Ethyl 4-(acetylthio)butyrate 
O
O
S
O
 
2.2. Isomers 
2.2.1. Status 
Two substances have one chiral centre [FL-no: 12.241 and 12.255] and three substances have two 
chiral centres [FL-no: 12.238, 12.239 and 12.291] in the group of the JECFA evaluated sulphides and 
thiols. 
2.2.2. EFSA Considerations 
Adequate information on isomeric composition is available for all the substances in FGE.74Rev3. For 
the two stereoisomeric substances [FL-no: 12.241 and 12.255] with one chiral centre, the CAS register 
number (CASrn) is considered to cover the stereoisomeric composition as a racemate. 
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2.3. Specifications 
2.3.1. Status 
The JECFA specifications are available for all 19 substances (JECFA, 1999b; JECFA, 2003). See 
Table 4. 
2.3.2. EFSA Considerations 
The available specifications are considered adequate for all 19 substances. (see Section 2.2). 
3. INTAKE ESTIMATION 
3.1. Status 
For all substances production volumes, based on which MSDI values can be calculated, are available 
for the EU, see Tables 3 and 10.  
3.2. EFSA Considerations 
For one JECFA evaluated substance [FL-no: 12.291], normal and maximum use levels have been 
provided by the Flavour Industry in accordance with the Commission Regulation (EC) No 1565/2000 
(Flavour Industry, 2008; EC, 2000) (see Table 2). Based on the normal use levels, the mTAMDI figure 
can be calculated (see Table 3). For calculation of mTAMDI figures, see e.g. FGE.03, Annex II 
(EFSA, 2004). 
Table 2:  Normal and Maximum Use Levels (mg/kg) available for the JECFA-evaluated substances 
in FGE.74Rev3 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.291 - 
- 
0.1 
0.5 
- 
- 
0.01 
0.1 
- 
- 
- 
- 
- 
- 
0.1 
1 
0.1 
2 
- 
- 
- 
- 
- 
- 
0.1 
1 
- 
- 
- 
- 
- 
- 
0.1 
1 
0.1 
0.5 
 
Table 3:  Estimated Intakes Based on the MSDI- and the mTAMDI Approach 
FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural class Thresho
ld of 
concern 
(µg/pers
on/day) 
12.013 Dimethyl trisulfide 1.1 0.02  Class I 1800 
12.020 Methyl propyl trisulfide 0.21 0.1  Class I 1800 
12.023 Dipropyl trisulfide 7.3 1  Class I 1800 
12.155 Methyl ethyl trisulfide 0.012 1  Class I 1800 
12.169 2-Methyl-4-oxopentane-2-thiol 0.69 0.02  Class I 1800 
12.179 2-(Methylthio)ethan-1-ol 0.97 0.9  Class I 1800 
12.198 2,3,5-Trithiahexane 0.024 0.04  Class I 1800 
12.212 Ethyl-5-(methylthio)valerate 1.8 2  Class I 1800 
12.238 3-Mercapto-2-methylpentan-1-ol 0.85 0.7  Class I 1800 
12.239 3-Mercapto-2-methylpentanal 2.6 4  Class I 1800 
12.241 2-Mercapto-2-methylpentan-1-ol 0.012 4  Class I 1800 
12.255 Ethyl 3-mercaptobutyrate 3.4 4  Class I 1800 
12.257 Ethyl 4-(acetylthio)-butyrate 3.4 4  Class I 1800 
12.280 Diisopropyl trisulphide 0.24 0.007  Class I 1800 
12.291 3-Mercapto-2-methyl-1-butanol 0.061 2 17 Class I 1800 
12.009 Diallyl trisulfide 3.5 0.02  Class II 540 
12.045 Methyl allyl trisulfide 0.012 0.9  Class II 540 
12.074 Diallyl polysulfides 1.2 0.02  Class II 540 
12.088 Diallyl sulfide 3.5 0.4  Class II 540 
 
Flavouring Group Evaluation 74 Revision 3
 
EFSA Journal 2014;12(6):3710 15
SUMMARY OF SPECIFICATION DATA 
Table 4:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 1999b; JECFA, 2003) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, °C (c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments 
12.009 
587 
Diallyl trisulfide S
S
S
 
3265 
486 
2050-87-5 
Liquid 
C6H10S3 
178.33 
Insoluble 
Insoluble 
112-120 (21hPa) 
 
IR 
65 % 
1.600-1.620 
1.135-1.170 
 
Min. Assay value 65 %, 
secondary components 
20-25 % allyl disulfide; 
5-7 % allylsulfide; 5-7 % 
allyl tetrasulfide (EFFA). 
12.013 
582 
Dimethyl trisulfide S
S
S
 
3275 
539 
3658-80-8 
Liquid 
C2H6S3 
126.26 
Very slightly 
soluble 
Soluble 
165-170 
 
IR 
97 % 
1.595-1.605 
1.195-1.210 
 
 
12.020 
584 
Methyl propyl trisulfide 
S
SS
 
3308 
586 
17619-36-2 
Liquid 
C4H10S3 
154.30 
Very slightly 
soluble 
Soluble 
52 (1.6 hPa) 
 
IR 
45 % 
1.558-1.570 
1.095-1.101 
 
Min. Assay value 45 %, 
secondary components 
25 % dipropyl trisulfide, 
12 % dipropyl disulfide, 
14 % dimethyl disulfide, 
3 % methyl propyl 
sulfide (EFFA). 
12.023 
585 
Dipropyl trisulfide S
S
S
 
3276 
726 
6028-61-1 
Liquid 
C6H14S3 
182.36 
Almost 
insoluble 
Soluble 
98 (5 hPa) 
 
IR 
99 % 
1.542-1.590 
0.952 
 
 
12.045 
586 
Methyl allyl trisulfide 
S
SS
 
3253 
11867 
34135-85-8 
Liquid 
C4H8S3 
152.29 
Very slightly 
soluble 
Soluble 
47 (1 hPa) 
 
NMR 
80 % 
1.593-1.603 
0.975-0.985 
 
Min. Assay value 80 %, 
secondary components 
10-12 % dimethyl 
trisulfide; 6-8 % allyl 
trisulfide (EFFA). 
12.074 
588 
Diallyl polysulfides 
SX
X=2,3,4 or 5  
3533 
11912 
72869-75-1 
Liquid 
C6H10S2 
146.30 
Insoluble 
Slightly soluble 
68 (20 hPa) 
 
IR NMR 
95 % 
1.643-1.653 
1.220 (20°) 
 
 
12.088 
458 
Diallyl sulfide S
 
2042 
11846 
592-88-1 
Liquid 
C6H10S 
114.21 
Insoluble 
Sparingly 
soluble 
138-139 
 
IR 
97 % 
1.488-1.492 
0.887-0.892 
 
Solubility in ethanol 
(EFFA, 2011). 
12.155 Methyl ethyl trisulfide 
S
S S 3861 Liquid Very slightly 46-47 (5 hPa) 1.510-1.520  
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Table 4:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 1999b; JECFA, 2003) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, °C (c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments 
583  
31499-71-5 
C3H8S3 
140.28 
soluble 
Soluble 
 
NMR 
97 % 
0.955-0.965  
12.169 
1293 
2-Methyl-4-oxopentane-
2-thiol SH
O
 
3997 
11500 
19872-52-7 
Liquid 
C6H12OS 
132.23 
Soluble 
Very slightly 
soluble 
47-49 (20 hPa) 
 
IR NMR MS 
48 % 
1.431-1.437 
1.032-1.037 
 
The Register name to be 
changed to 4-mercapto-
4-methyl-2-pentanone. 
Min. assay value is 48 % 
and secondary 
component 4-methyl-3-
penten-2-one [FL-no: 
07.101] 48-50 % 
(EFFA); supplied as a 1 
% solution in propylene 
glycol. 
12.179 
1297 
2-(Methylthio)ethan-1-ol 
HO
S
 
4004 
11545 
5271-38-5 
Liquid 
C3H8OS 
92.16 
Insoluble 
Soluble 
169-171 
 
IR NMR MS 
98 % 
1.490-1.498 
1.055-1.065 
(20º) 
 
 
12.198 
1299 
2,3,5-Trithiahexane S S
S  
4021 
 
42474-44-2 
Liquid 
C3H8S3 
140.30 
Insoluble 
Soluble 
56-58 (10 hPa) 
 
MS 
95 % 
1.436-1.444 
1.157-1.163 
 
 
12.212 
1298 
Ethyl-5-
(methylthio)valerate 
O
O S  
3978 
 
233665-98-0 
Liquid 
C8H16O2S 
176.27 
Insoluble 
Soluble 
227 
 
IR NMR MS 
96 % 
1.460-1.464 
0.993-1.003 
(20º) 
 
Register name to be 
changed to ethyl 5-
(methylthio)valerate. 
12.238 
1291 
3-Mercapto-2-
methylpentan-1-ol OH
SH  
3996 
 
227456-27-1 
Liquid 
C6H14OS 
134.24 
Slightly soluble 
Soluble 
50 (0.7 hPa) 
 
IR NMR 
99 % 
1.480-1.490 
0.985-0.995 
 
Mixture of four 
diastereoisomers, each 
about 25 % (EFFA, 
2014). 
12.239 
1292 
3-Mercapto-2-
methylpentanal O
HS  
3994 
 
227456-28-2 
Liquid 
C6H12OS 
132.23 
Insoluble 
Soluble 
98-100 (13 hPa) 
 
IR 
96 % 
1.523-1.529 
1.095-1.103 
 
Mixture of four 
diastereoisomers, each 
about 25 % (EFFA, 
2014). 
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Table 4:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 1999b; JECFA, 2003) 
FL-no 
JECFA
-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility (a) 
Solubility in 
ethanol (b) 
Boiling point, °C (c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
(d) 
Spec.gravity 
(e) 
EFSA comments 
12.241 
1290 
2-Mercapto-2-
methylpentan-1-ol HO
SH
 
3995 
 
258823-39-1 
Liquid 
C6H14OS 
134.24 
Slightly soluble 
Soluble 
57-59 (0.8 hPa) 
 
IR NMR 
99 % 
1.476-1.483 
0.968-0.974 
(20º) 
 
Racemate. CASrn is 
considered to cover the 
stereoisomeric 
composition as racemate. 
12.255 
1294 
Ethyl 3-
mercaptobutyrate 
O
O SH  
3977 
 
156472-94-5 
Liquid 
C6H12O2S 
148.22 
Insoluble 
Soluble 
188 
 
IR NMR MS 
97 % 
1.448-1.453 
1.011-1.021 
(20º) 
 
Racemate.  CASrn is 
considered to cover the 
stereoisomeric 
composition as racemate. 
12.257 
1295 
Ethyl 4-(acetylthio)-
butyrate O
O
S
O
3974 
 
104228-51-5 
Liquid 
C8H14O3S 
190.26 
Insoluble 
Soluble 
262 
 
IR NMR MS 
96 % 
1.468-1.472 
1.073-1.083 
(20º) 
 
 
12.280 
1300 
Diisopropyl trisulphide 
S
S
S  
 
 
5943-34-0 
Liquid 
C6H14S3 
182.40 
Insoluble 
Soluble 
107-108(13 hPa) 
 
NMR MS 
95 % 
1.441-1.445 
1.134-1.140 
 
 
12.291 
1289 
3-Mercapto-2-methyl-1-
butanol 
OH
SH
 
3993 
 
227456-33-9 
Liquid 
C5H12OS 
120.21 
Slightly soluble 
Freely soluble 
98 (at 2.7 hPa) 
 
IR NMR MS 
98 % 
1.482-1.490 
1.002-1.008 
 
Mixture of four 
diastereoisomers, each 
about 25 % (EFFA, 
2014). 
(a): Solubility in water, if not otherwise stated. 
(b): Solubility in 95 % ethanol, if not otherwise stated. 
(c): At 1013.25 hPa, if not otherwise stated. 
(d): At 20°C, if not otherwise stated. 
(e): At 25°C, if not otherwise stated. 
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4. GENOTOXICITY DATA 
4.1. Genotoxicity Studies – Text Taken8 from the JECFA Report (JECFA, 2000; 
JECFA, 2004b) 
Reverse mutation test was performed for diallyl sulphide [FL-no: 12.088] (0.004 - 0.44 µg/ml), using 
S. typhimurium strain TA100. No genotoxicity was observed (Eder et al., 1982)9. 
Groups of male ICR mice were given two doses 48 hours apart of a mixture containing diallyl 
sulphide [FL-no: 12.088], allyl disulphide (JECFA-no: 572), or diallyl trisulphide [FL-no: 12.009] in 
corn oil at doses of 10 or 20 mg/ml by gavage. The doses were estimated to provide 0.33 or 0.67 
mmol/kg bw or 50 or 100 mg/kg bw on the basis of the composition of the mixture. No increase in the 
frequency of micronucleated polychromatic erythrocytes was seen in bone-marrow cells (Marks et al., 
1992). 
Erythro- and threo-3-mercapto-2-methylbutanol [FL-no: 12.291 (3-mercapto-2-methyl-1-butanol)] (50 
– 5000 µg/plate) was evaluated for mutagenic activity in the modified Ames test with pre-incubation 
in the presence and absence of metabolic activation in S. typhimurium strains TA97, TA98, TA100, 
TA102 and TA1535. No genotoxic effects were observed (Gocke, 1997). 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Table 6. 
4.2. Genotoxicity Studies – Text Taken10 from EFSA FGE.08Rev5 (EFSA CEF 
Panel, 2012b) 
In vitro / in vivo 
Genotoxicity in vitro data are available for three candidate substances: di-(1-propenyl)-sulphide 
(mixture) [FL-no: 12.298] (subgroup I), 2-methylpropane-2-thiol [FL-no: 12.174] (subgroup III), 
dibutyl disulphide [FL-no: 12.111] (subgroup V). In addition studies are available on 11 supporting 
substances from subgroups I (1), III (4), V (4) and VIII (2). 
In vivo data are available for three supporting substances from subgroups I (1), III (1) and V (1).   
Subgroup I (Acyclic sulphides) 
In vitro data are available for the candidate substance, di-(1-propenyl)-sulphide [FL-no: 12.298]; 
Ames test: S. typhimurium TA98, TA100, TA102, TA1535, TA1537, 1-100 µg/plate. Result was 
negative with and without metabolic activation (Stien, 2005). 
For supporting substances, only data on diallyl sulphide [FL-no: 12.088] are available. Diallyl 
sulphide was negative in a limited bacterial reversion assay using one strain only (TA100) and 
provided equivocal results in an in vitro cytogenetic test in which increased incidences of cells with 
chromosomal aberrations and sister chromatid exchanges (SCEs), statistically significant but not dose 
related, were observed. In vivo diallyl sulphide was evaluated as negative in a micronucleus test in 
mouse bone marrow, which was, however, not designed to evaluate the genotoxicity of the substance 
itself as it was tested in a mixture. Overall the data available do not allow evaluation of the 
genotoxicity of the substances of this subgroup.  
 
                                                     
8  The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. 
9  The Panel noted that the publication of Eder et al., 1982 is not the correct paper to quote from. It has not been possible for 
EFSA to identify the correct paper.  
10  The text is taken from the indicated reference source, but text related to subgroups not included in the present FGE has 
been removed. 
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Subgroup III (Monothiols) 
2-Methylpropane-2-thiol [FL-no: 12.174] is reported to be negative in an Ames test. It is reported to 
be positive in a mouse lymphoma assay without metabolic activation and negative in the test with 
metabolic activation, and it is reported to be negative in an in vitro SCE assay. However, these studies 
are reported only as summaries (Phillips Petroleum Company, 1990a). Some details are available for 
methods but not for the results. Although the validity of these studies cannot be fully evaluated, the 
positive result in the mouse lymphoma assay raises concern with respect to the potential for 
genotoxicity of this tertiary thiol and structurally related compounds, i.e. candidate substance 2-
methylbutane-2-thiol [FL-no: 12.172] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and 
the five supporting substances [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145]. 
The in vitro data available for the other substances in this subgroup do not provide indication of 
concern for genotoxicity. 
Subgroup V (Acyclic and Cyclic disulphides) 
Dibutyl disulphide [FL-no: 12.111] is reported to be negative in a mouse lymphoma assay (Dooley et 
al., 1987). However, the study is reported only as an abstract, and thus, the validity cannot be 
evaluated.  
Further data are available for the supporting substances diallyl disulfide [FL-no: 12.008], 
dimethyldisulphide [FL-no: 12.026], phenyl disulfide [FL-no: 12.043] and benzyl disulfide [FL-no: 
12.081]. All substances were reported to be negative in the Ames test. In addition, diallyl disulphide 
was reported to be positive in a chromosomal aberration assay in vitro, with and without metabolic 
activation, and weakly positive in a SCE assay. However, the validity of these findings is doubtful as 
chromosomal aberrations were only increased in conditions associated with extensive (> 90 %) 
lethality, and because of the limitation of SCE in genotoxic hazard identification. 
Subgroup VI (Acyclic tri- and polysulphides) 
No genotoxicity information of sufficient quality is available. 
Subgroup VIII (Thioesters) 
The in vitro data available on supporting substances provide no indication of concern for genotoxicity. 
Conclusion on genotoxicity 
Most in vitro and in vivo studies are of limited or insufficient quality and provide only limited 
information.  
The available data raise concern with respect to genotoxicity of three tertiary thiols [FL-no: 12.172, 
12.174 and 12.304], included as candidate substances in subgroup III. Hydrolysis of the candidate 
substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], included in subgroup VII, leads to the 
formation of a tertiary thiol structurally related to the above-mentioned compounds. Therefore, there is 
also concern with respect to genotoxicity of this candidate substance. The Panel noted that in FGE.08 
five of the supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 
12.145] for which a concern for genotoxicity has been raised in the FGE.08Rev1. These supporting 
substances have been evaluated by the JECFA at the 53rd meeting (JECFA, 2000b; JECFA, 2000). 
These supporting substances have been considered by EFSA in FGE.91 (EFSA CEF Panel, 2010b). 
In addition, genotoxicity of the candidate substance methyl methanethiosulphonate [FL-no: 12.159], 
included in subgroup X, could not be assessed from the data available. However, due to the similarity 
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with methyl methanesulphonate, a direct acting mutagen and carcinogen, there is concern with respect 
to genotoxic potential of this candidate substance.  
Therefore, the Panel decided that the Procedure could not be applied to the candidate substances [FL-
no: 12.159, 12.172, 12.174, 12.304 and 16.057] until adequate in vivo genotoxicity data become 
available. 
The other in vitro/in vivo genotoxicity data available, often from limited or poorly reported studies do 
not provide clear indication of concern for genotoxicity for the remaining candidate substances 
included in the present evaluation. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA, see Tables 7 and 8 of this 
FGE. 
4.3. New Genotoxicity Study on 2-Methyl-4-oxopentane-2-thiol [FL-no: 12.169] 
In vitro 
2-Methyl-4-oxopentane-2-thiol [FL-no: 12.169] was tested in S. typhimurium strains TA98, TA100, 
TA102, TA1535 and TA1537 in the presence or absence of S9-mix (Mc Garry, 2012). In the first 
experiment, the concentrations tested were 5.0, 15.8, 50.0, 158.1, 500.0, 1581 and 5000 μg/plate, and 
the plate incorporation method was used. No evidence of toxicity was observed in the absence or 
presence of S9-mix in any tester strains. In the second experiment, the concentrations were 156.3, 
312.5, 625.0, 1250, 2500 and 5000 μg/plate of 2-methyl-4-oxopentane-2-thiol, and treatments in the 
presence of S9-mix used the pre-incubation method. Evidence of toxicity was observed through slight 
thinning of the background lawn and/or marked reduction in revertant numbers in all strains at 2500 
and/or 5000 μg/plate in the presence of S9-mix and in TA1537 in the absence of S9-mix. Thus, the 
study design complied with current recommendations and an acceptable top concentration was 
achieved. There was no evidence of any mutagenic effect induced by 2-methyl-4-oxopentane-2-thiol 
in any of the strains, either in the absence or presence of S9-mix. 
For a summary of the genotoxicity data on 2-methyl-4-oxopentane-2-thiol, see Table 9. 
4.4. EFSA Considerations  
Subgroup III includes the tertiary thiols for which a genotoxicity concern was established based on 
data from a limited gene mutation assay for candidate substances in FGE.08Rev1 [FL-no: 12.174] and 
additional genotoxicity data were requested for this group of substances. Since the publication of the 
latest revision of FGE.08, FGE.08Rev5 the Industry has submitted a new bacterial mutation assay for 
the tertiary thiol [FL-no: 12.169] included in FGE.74. This substance is considered by the Panel to be 
representative for the whole group of tertiary thiols (in FGE.08, FGE.74 and FGE.91). Based on the 
new genotoxicity data the Panel concluded that 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] was 
not genotoxic in the assay and that 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] and 2-mercapto-2-
methylpentan-1-ol [FL-no: 12.241] do no longer give rise to concern with respect to gene mutations. 
Therefore, these two substances can be evaluated using the Procedure in the present FGE. The Panel 
noted that of the material of commerce for [FL no: 12.169], approximately half consists of the α,β-
unsaturated carbonyl, 4-methyl-3-penten-2-one [FL-no: 07.101], for which concern for genotoxicity 
was ruled out in FGE.204 (EFSA CEF Panel, 2012a) and evaluated using the Procedure in 
FGE.63Rev2 (EFSA CEF Panel, 2013). 
Although the available data are limited11 the Panel considered that for the 19 substances in 
FGE.74Rev3 the genotoxicity data do not preclude evaluating these substances through the Procedure. 
                                                     
11  The Panel noted that few days before the adoption of the Opinion EFFA provided a new in vivo micronucleus study on  
  [FL-no:12.169] which will be considered in the next revision of this Opinion. 
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5. Considerations about Additional Data Submitted for the Tri- and Polysulphides 
in FGE.74 
Based on the new data submitted for the tri- and polysulphides, the Panel concluded as follows: 
In the earlier EFSA-evaluations of acyclic tri- and polysulphides (subgroup VI in FGE.08), the 
evaluation stopped at step B4 due to lack of NOAEL for a representative substance. The available 90-
day feeding studies on dipropyltrisulphide and diallyltrisulphide by Morgareidge and Oser 
(Morgareidge and Oser, 1970a; Morgareidge and Oser, 1970b) were not considered good enough for 
derivation a NOAEL, and the reasons given was that the studies lacked information on the stability of 
the test substances, and that histopathology results were missing. 
The shortcomings of the Morgareidge and Oser studies are (still) the following: 
• no data on the stability of the test substance in feed is given. 
• nearly all animals, including control animals, were affected by inflammatory changes in 
respiratory tract, and in other organs (mainly liver). These changes (probably caused by infections) 
prohibit adequate interpretation of the study results. 
• the data on haematology, clinical chemistry and urine analysis (performed for eight animals in the 
test-substance groups respectively, and eight animals in the control group at weeks 6 and 12) are 
only shown as a mean for the three groups, and without any indication of variation between the 
individuals (e.g. no SD etc.). 
 
Thus the studies are not adequate for derivation of a NOAEL. 
The additional data submitted contains general information on biology and metabolism of 
polysulphides as well as toxicological data. The general information on metabolism and structure-
activity relationships of sulphides is mainly in accordance with what is referred in FGE.08 and 
FGE.74. 
Industry also submitted a discussion with the aim to show that NOAELs from toxicity studies for 
sulphides, disulphides and for tri- and polysulphides are of the same magnitude. In this discussion, 
route to route extrapolation was applied, but the technique to accomplish this has been presented as 
being inadequate  (Rennen et al., 2004). Additionally, the oral long-term studies that are referred to are 
one-dose-level-only studies, and as such it is not appropriate to use the NOAELs derived from these 
studies for comparing the magnitudes with NOAELs from other studies. The discussion on magnitude 
of NOAELs is therefore not considered relevant. Therefore, the Panel concluded that the 
extrapolations made by the applicant cannot be used to support derivation of a NOAEL for the oral 
route. 
Thus, the Panel concluded that the additional information as submitted by Industry (IOFI, 2013) is 
insufficient to evaluate the safety of the tri- and polysulphides. There is still need for a 90-day study 
from which a NOAEL can be derived with which the safety of these substances can be evaluated. 
6. Application of the Procedure 
6.1. Application of the Procedure to 19 Simple Aliphatic Sulphides and Thiols 
Evaluated by the JECFA (JECFA, 2000; JECFA, 2004b) 
According to JECFA 15 substances belong to structural class I and four to structural class II using the 
decision tree approach presented (Cramer et al., 1978). 
None of the substances could be anticipated to be metabolised to innocuous products and all were 
evaluated via the B-side of the Procedure. The estimated daily per capita intakes of the 19 flavouring 
substances are below the threshold of concern for structural class I and II, and a No Observed Adverse 
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Effect Level (NOAEL) exists to provide an adequate margin of safety to the estimated intake as 
flavouring substances (step B4). 
Step B4  
For erythro- and threo-3-mercapto-2-methylbutanol [FL-no: 12.291(3-mercapto-2-methyl-1-butanol)], 
the NOEL of 0.7 mg/kg body weight per day for the structurally related substance 2-mercapto-3-
butanol [FL-no: 12.024] from a 92-day study in rats fed by gavage (Cox et al., 1974) provides an 
adequate margin of safety (> 10.000) in relation to known levels of intake of this agent.  
This NOEL is also appropriate for the structurally related agents (±)-2-mercapto-2-methylpentan-1-ol 
[FL-no: 12.241], 3-mercapto-2-methylpentan-1-ol (racemic) [FL-no: 12.238], 3-mercapto-2-
methylpentanal [FL-no: 12.239], and (±)-ethyl 3-mercaptobutyrate [FL-no: 12.255], because they are 
all acyclic thiols with oxidized side-chains that are anticipated to undergo oxidation or hydrolysis and 
subsequent metabolism via similar metabolic pathways. 
For 4-mercapto-4-methyl-2-pentanone [FL-no: 12.169], the NOEL of 1.9 mg/kg bw per day for the 
structurally related substance 3-mercapto-2-pentanone [FL-no: 12.031] administered to rats by gavage 
in a 92-day study (Morgareidge, 1971) provides an adequate margin of safety (> 10,000) in relation to 
known levels of intake of this agent. 
For ethyl 4-(acetylthio)butyrate [FL-no: 12.257], the NOEL of 6.5 mg/kg bw per day reported in a 13-
week study in rats (Shellenberger, 1970) fed with the structurally related substance ethylthioacetate 
[FL-no: 12.018] provides an adequate margin of safety (>10,000) in relation to known levels of intake 
of this agent. 
For 2-(methylthio)ethanol [FL-no: 12.179], the NOEL of 1.4 mg/kg bw per day reported in a 13-week 
study in rats (Cox et al., 1979) fed by gavage with the structurally related substance 2-
(methylthiomethyl)-3-phenylpropenal [FL-no: 12.087] provides an adequate margin of safety 
(>10,000) in relation to known levels of intake of this agent. This NOEL is also appropriate for the 
structurally related agent ethyl-5-(methylthio)valerate [FL-no: 12.212], which is also an acyclic 
sulphide with an oxidized side-chain that is anticipated to undergo oxidation and subsequent 
metabolism via similar pathways. 
For 2,3,5-trithiahexane [FL-no: 12.198], the NOEL of 0.3 mg/kg bw per day reported in a 13-week 
study (Mondino, 1981) in rats fed with the structurally related substance 3-methyl-1,2,4-trithiane [FL-
no: 15.036] provides an adequate margin of safety (> 10,000) in relation to known levels of intake of 
this agent. 
For diisopropyl trisulphide [FL-no: 12.280], the NOEL of 4.8 mg/kg bw per day reported in a 13-week 
study (Morgareidge and Oser, 1970a) in rats fed by gavage with the structurally related substance 
dipropyl trisulphide [FL-no: 12.023] provides an adequate margin of safety (>100,000) in relation to 
known levels of intake of this agent.  
For diallyl trisulphide [FL-no: 12.009] and dipropyl trisulphide [FL-no: 12.023], the NOELs of 4.6 
mg/kg bw per day and 4.8 mg/kg bw per day, respectively were reported in a 90 days study 
(Morgareidge and Oser, 1970a; Morgareidge and Oser, 1970b) at a single dose, which gave adequate 
margins of safety for [FL-no: 12.013, 12.020, 12.045, 12.074 and 12.155]. The dose that had no effect 
is more than 10.000 times greater than the estimated per capita intake in Europe and more than 
100,000 times higher than the estimated per capita intake in the United States. 
No adequate NOEL was available for diallyl sulphide [FL-no: 12.088] or a related substance, therefore 
no adequate margin of safety can be provided. Accordingly, the evaluation of the substance proceeds 
to step B5.  
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Step B5  
For diallyl sulphide [FL-no: 12.088] the intake is estimated to be 0.4 µg/capita/day in the USA, which 
is lower than 1.5 µg/day, therefore the JECFA has concluded that there is no safety concern based on 
the intake data. 
In conclusion the JECFA evaluated all substances as to be of no safety concern at the estimated levels 
of intake as flavouring substances based on the MSDI approach. 
The evaluations of the 19 simple aliphatic sulphides and thiols with the outcome of the JECFA-
evaluations are summarised in Table 10 of this FGE. 
6.2. Application of the Procedure to Aliphatic and Alicyclic Mono-, Di-, Tri-, and 
Polysulphides with or without Additional Oxygenated Functional Groups 
Evaluated by EFSA in FGE.08Rev5 (EFSA CEF Panel, 2012b)12 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
For the candidate substance methyl methanethiosulphonate [FL-no: 12.159] (the only substance in 
subgroup X), there is an indication of a genotoxic potential in vitro. Furthermore, for three candidate 
substances (in subgroup III), 2-methylbutane-2-thiol [FL-no: 12.172], 2-methylpropane-2-thiol [FL-
no: 12.174] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and one candidate substance 
(in subgroup VII), 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], a concern for genotoxicity was also 
identified based on experimental evidence for [FL-no: 12.174] and the structural similarity among 
these four substances. Therefore, in the absence of further genotoxicity data, the Panel concluded that 
the Procedure could not be applied to these five substances.  
For four candidate substances, 3-mercaptooctanal [FL-no: 12.268] (subgroup III), 3-mercaptodecanal 
[FL-no: 12.269] (subgroup III), methanedithiol diacetate [FL-no: 12.271] (subgroup VIII) and 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] (subgroup V) no data on use as flavouring substances 
in Europe are available. Therefore, no intakes in Europe can be estimated and accordingly the Panel 
concluded that the Procedure could not be applied to these four substances.  
Thus, for in total nine candidate substances the Procedure could not be applied: [FL-no: 12.159, 
12.172, 12.174, 12.268, 12.269, 12.271, 12.295, 12.304 and 16.057]. 
For the safety evaluation of the remaining 71 candidate substances from chemical groups 20 and 30 
the Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise 
evaluations of the 71 substances evaluated through the Procedure are summarised in Table11. 
Step 1 
The candidate substances were classified following the procedure established by Cramer et al. (Cramer 
et al., 1978). For the 71 candidate substances evaluated through the Procedure, 42 substances were 
classified into structural class I, 19 substances were classified into structural class II and 10 substances 
were classified into structural class III. 
Step 2 
Step 2 requires consideration of whether metabolic pathways exist to metabolise the candidate 
substances to innocuous products at the expected levels of intake. The candidate substances may be 
biotransformed to reactive metabolites, such as thiols, sulphoxides and sulphones and, in consequence, 
                                                     
12 The text is taken verbatim from the indicated reference source, but text related to subgroups not included in the present 
FGE has been removed 
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they are not predicted to be metabolised to innocuous products. Therefore, the evaluation of all 71 
candidate substances proceeds via the B-side of the Procedure scheme. 
Step B3 
The 42 substances in structural class I have estimated European daily per capita intakes ranging from 
0.0012 to 6.1 µg, which is below the threshold of concern of 1800 µg/person/day. The 19 substances 
evaluated through the Procedure in structural class II have estimated European daily per capita intakes 
ranging from 0.0024 to 2.4 µg, which is below the threshold of concern for class II of 540 
µg/person/day. The 10 substances in structural class III have estimated European daily per capita 
intakes from 0.012 to 6.1µg, which is below the threshold of concern for class III of 90 µg/person/day. 
Accordingly, all 71 candidate substances proceed to step B4 of the Procedure. 
Step B4 
No adequate studies on candidate substances are available. Repeated-dose toxicity studies are 
available on some supporting substances, which, with very few exceptions, have been carried out 
testing only one dose, giving rise to no observed adverse effects. The results of the adequate studies on 
supporting substances show a relatively high degree of variability in the reported No Observed 
Adverse Effect Levels (NOAELs), ranging from 0.06 to 250 mg/kg bw/day.  
The 20 candidate substances in subgroup I can be represented by the supporting substance dimethyl 
sulphide [FL-no: 12.006], for which an adequate 90-day subchronic study is available, indicating that 
no adverse effects were produced by the highest oral dose tested (250 mg/kg bw/day), which can be 
considered a NOAEL. The combined estimated daily per capita intake of 10 µg for the 18 candidate 
substances in subgroup I corresponds to 0.17 µg/kg bw/day at a body weight of 60 kg. Thus, a margin 
of safety of 1.5 x 106 can be calculated. The 20 candidate substances in subgroup I are accordingly not 
expected to be of safety concern at the estimated levels of intake. 
Within subgroup III, adequate 90-day subchronic studies are available for four supporting secondary 
thiols, 2-mercapto-3-butanol [FL-no: 12.024], cyclopentanethiol [FL-no: 12.029], 2,3- and 10-
mercaptopinane [FL-no:12.035] and 2,6-(dimethyl)thiophenol [FL-no: 12.082], which can be 
considered representative of the 11 candidate substances evaluated through the Procedure in this 
subgroup. In the four studies, no adverse effects were produced by the highest oral dose tested ranging 
from 0.06 up to 0.7 mg/kg bw/day. By adopting a conservative approach the lowest value (0.06 mg/kg 
bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 1.13 µg for 
the 11 candidate substances evaluated through the Procedure in subgroup III corresponds to 0.019 
µg/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3 x 103 can be calculated. The 11 
candidate substances in subgroup III are accordingly not expected to be of safety concern at the 
estimated levels of intake. 
Within subgroup V, adequate 90-day subchronic studies are available for two supporting substances 
dicyclohexyl disulfide [FL-no: 12.028] and benzyl methyl disulfide [FL-no: 12.068], which can be 
considered representative of the four candidate substances in this subgroup evaluated through the 
Procedure. In the two studies, no adverse effects were produced by the highest oral dose tested: 0.23 
and 1.15 mg/kg bw/day. By adopting a conservative approach, the lowest value (0.23 mg/kg bw/day) 
can be considered a NOAEL. The combined estimated daily per capita intake of 0.6 µg for the four 
candidate substances evaluated through the Procedure in subgroup V corresponds to 0.01 µg/kg 
bw/day at a body weight of 60 kg. Thus, a margin of safety of 2.3 x 104 can be calculated. The four 
candidate substances in subgroup V are accordingly not expected to be of safety concern at the 
estimated levels of intake. 
Within subgroup VI, no adequate toxicity study from which a NOAEL could be established was 
available, neither on the candidate substances nor on supporting substances. Therefore, the Panel 
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concluded that additional data are required for the eight tri-, tetra- and polysulphides in subgroup VI 
[FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 12.167]. 
Within subgroup VIII, an adequate 90-day subchronic study is available for one supporting substance, 
ethyl thioacetate [FL-no: 12.018], which can be considered representative of the eight candidate 
substances evaluated through the Procedure in this subgroup. In the study, no adverse effects were 
produced by the highest oral dose tested: 6.63 mg/kg bw/day. Therefore, the NOAEL is concluded to 
be 6.63 mg/kg bw per day for ethyl thioacetate. The combined estimated daily per capita intake of 2.4 
µg for the eight candidate substances in subgroup VIII corresponds to 0.04 µg/kg bw/day at a body 
weight of 60 kg. Thus, a margin of safety of 1.7 x 105 can be calculated. The eight candidate 
substances in subgroup VIII are accordingly not expected to be of safety concern at the estimated 
levels of intake. 
The conclusion from step B4 is that for the 43 candidate substances belonging to subgroups I, III, V 
and VIII, and evaluated through the Procedure, adequate NOAELs exist for the candidate substance or 
for structurally related substances providing adequate margins of safety at the estimated levels of 
intake. Therefore, these candidate substances are not expected to be of safety concern at the levels of 
exposure estimated by the MSDI approach.  
For the eight candidate substances belonging to subgroup VI [FL-no: FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.164 and 12.167] additional toxicity data are required. 
The evaluations of the aliphatic and alicyclic mono-, di-, tri-, and polysulphides are summarised in 
Table 11. 
6.3. EFSA Considerations  
The 19 JECFA evaluated simple aliphatic sulphides and thiols are distributed into five subgroups of 
structurally related substances. The sub-grouping is in compliance with the one used in FGE.08Rev5 
(see Section 2.1.2 and Table 1). 
Althoug the available data are limited the Panel considered that for the remaining 19 substances in 
FGE.74Rev3 the genotoxicity data do not preclude evaluating these substances through the Procedure. 
The Panel agrees with the application of the Procedure as performed by the JECFA for five simple 
aliphatic sulphides and thiols, namely [FL-no: 12.238, 12.239, 12.255, 12.257 and 12.291]. 
For 14 substances [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074, 12.088, 12.155, 12.169, 
12.179, 12.198, 12.212, 12.241 and 12.280] the Panel did not agree with the application of the 
Procedure by the JECFA for the following reasons: 
The JECFA derives a NOAEL of 1.4 mg/kg bw per day reported in a 13-week study in rats (Cox et al., 
1979) fed by gavage with 2-(methylthiomethyl)-3-phenylpropenal [FL-no: 12.087]. The Panel did not 
agree with the JECFA that 2-(methylthiomethyl)-3-phenylpropenal [FL-no: 12.087] is structurally 
related to 2-(methylthio)ethan-1-ol [FL-no: 12.179] or ethyl-5-(methylthio)-valerate [FL-no: 12.212]. 
The JECFA derived a NOAEL of 0.3 mg/kg bw per day reported in a 13-week study (Mondino, 1981) 
in rats fed with 3-methyl-1,2,4-trithiane [FL-no: 15.036]. The Panel does not agree with the JECFA 
that 2,3,5-trithiahexane [FL-no: 12.198] is structurally related to 3-methyl-1,2,4-trithiane [FL-no: 
15.036].  
However, in the first revision of FGE.74, FGE.74Rev1, all substances have been distributed to 
subgroups with respect to sulphur-containing functional groups, according to FGE.08 and following 
revisions. The JECFA evaluated substances 2-(methylthio)ethan-1-ol and ethyl-5-(methylthio)valerate 
[FL-no: 12.179 and 12.212] have been allocated to subgroup I, Acyclic sulphides, and 2,3,5-
trithiahexane [FL-no: 12.198] has been allocated to subgroup V, Acyclic and cyclic disulphides. 
Appropriate NOAELs exist for these two subgroups, as is argued in FGE.08Rev5. Since based on 
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these NOAELs adequate margins of safety can be calculated for [FL no: 12.179, 12.198 and 12.212], 
in line with the JECFA, the Panel also concludes that these substances are not expected to be of safety 
concern at the estimated levels of intake. 
For the diallyl sulphide [FL-no: 12.088] the JECFA evaluated this substance at step B5 of the 
Procedure to be of no safety concern as the estimated intake in the USA of 0.4 µg/capita/day is below 
1.5 µg/day. In line with the opinion expressed by the Scientific Committee on Food (SCF, 1999), the 
Panel does not make use of this threshold of 1.5 µg per person per day. However, this substance is 
allocated subgroup I, for which an appropriate NOAEL (reported for dimethylsulphide [FL-no: 
12.006]) exist, as is demonstrated in FGE.08Rev5. The NOAEL of 250 mg/kg bw/day provides a 
margin of safety of 4.3 x 106 based on a European MSDI of 3.5 µg/capita/day and accordingly the 
Panel concludes that this substance is not expected to be of safety concern at the estimated level of 
intake.  
Industry indicated that for the two tertiary thiols, 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169] and 
2-mercapto-2-methylpentan-1-ol [FL-no: 12.241], both from subgroup III, the JECFA derives a 
NOAEL from 90-day studies performed with secondary thiols (3-mercapto-3-butanol [FL-no: 12.031] 
(Morgareidge, 1971) and 2-mercapto-3-butanol [FL-no: 12.024] (Cox et al., 1974), respectively. The 
Panel did not agree with the JECFA that the tertiary  and secondary thiols are sufficiently structurally 
related for a reading across with respect to deriving a NOAEL. Accordingly, the Panel concluded at 
step B4 that further data are required for the evaluation of [FL-no: 12.169 and 12.241]. 
For the eight substances in subgroup VI (acyclic tri- and polysulphides) [FL-no: 12.009, 12.013, 
12.020, 12.023, 12.045, 12.074, 12.155 and 12.280], 90-day studies were available on [FL-no: 12.009 
and 12.023], but the studies were not considered adequate for deriving a NOAEL (Morgareidge and 
Oser, 1970a; Morgareidge and Oser, 1970b) (see FGE.08Rev3 Section 8.2 (There are no data on 
stability of test substances and no results reported from histopathological examinations)). It has also 
been concluded that tri- and poly-sulphides cannot be covered by NOAELs for disulphides, due to the 
formation of more reactive metabolites than is the case for the disulphides. Accordingly, the Panel 
concluded at step B4 (contrary to JECFA) that further data are required for the tri- and polysulphides 
[FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074, 12.155 and 12.280]. 
In summary: No safety concern was identified for the following substances: [FL-no: 12.088, 12.179, 
12.198, 12.212, 12.238, 12.239, 12.255, 12.257 and 12.291]. For the remaining substances [FL-no: 
12.009, 12.013, 12.020, 12.023, 12.045, 12.074, 12.155, 12.169, 12.241 and 12.280], additional 
toxicity data is requested. 
An overview of the EFSA considerations is given in Table 5 below. 
Table 5:  Overview of Supporting Substances Providing Adequate NOAEL for the Procedure 
Step B4 
FL-no:  Register name Structural formula NOAEL provider 
I Acyclic sulphides 
12.088 Diallyl sulphide S  
S
 
12.179 2-(Methylthio)ethan-1-ol HO
S
 
S
 
12.212 Ethyl-5-(methylthio)valerate 
O
O S
S
 
III Monothiols 
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Table 5:  Overview of Supporting Substances Providing Adequate NOAEL for the Procedure 
Step B4 
12.169 2-Methyl-4-oxopentane-2-thiol 
SH
O
 
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
 
12.238 3-Mercapto-2-methylpentan-1-ol OH
SH
SH
HO
12.239 3-Mercapto-2-methylpentanal 
O
HS
SH
HO
12.241 2-Mercapto-2-methylpentan-1-ol HO
SH
 
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.255 Ethyl 3-mercaptobutyrate 
O
O SH  
SH
HO
12.291 3-Mercapto-2-methyl-1-butanol 
OH
SH
SH
HO
V Acyclic and cyclic disulphides 
12.198 2,3,5-Trithiahexane S S S  
S
S
 
and 
S
S
 
VI Acyclic tri- and polysulphides 
12.009 Diallyl trisulfide S S
S
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.013 Dimethyl trisulfide S S
S
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.020 Methyl propyl trisulfide S
SS
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.023 Dipropyl trisulfide S S
S
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.045 Methyl allyl trisulfide S
SS
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.074 Diallyl polysulfides 
SX
X=2,3,4 or 5
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.155 Methyl ethyl trisulfide S
S S
 
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
12.280 Diisopropyl trisulphide 
S
S
S
No adequate NOAEL available for step B4 in 
the Procedure – additional data required 
VIII Thioesters 
12.257 Ethyl 4-(acetylthio) butyrate 
O
O
S
O
O
S  
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The results of the evaluation of the 19 candidate substances in this FGE have been included in Table 
10. 
CONCLUSION  
In Flavouring Group Evaluation 74, Revision 3 (FGE.74Rev3) the EFSA considered 12 simple 
aliphatic sulphides and thiols evaluated by the JECFA at its 61st meeting and seven trisulphides and 
one monosulphide in a group of simple aliphatic and aromatic sulphides and thiols evaluated at its 53rd 
meeting. Accordingly the consideration dealt with 19 JECFA evaluated substances. 
The Panel concluded that the 19 substances in the JECFA flavouring group of simple aliphatic 
sulphides and thiols are structurally related to a group of aliphatic and alicyclic mono-, di-, and 
polysulphides with or without additional oxygenated functional groups evaluated by EFSA in the 
Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5).  
This revision is made due to additional genotoxicity data have been submitted for 4-mercapto-4-
methyl-2-pentanone [FL-no: 12.169]. In addition, for seven substances [FL-no: 12.009, 12.020, 
12.045, 12.169, 12.238, 12.239 and 12.291] new data on specifications have been included. Industry 
also submitted additional information intended to support the derivation of a NOAEL for substances in 
subgroup VI (tri- and poly-sulphides). 
In previous versions of this FGE a concern with respect to genotoxicity was identified for two 
candidate substances [FL-no: 12.169 and 12.241]. Additional genotoxicity data have now become 
available for 2-methyl-4-oxopentane-2-thiol [FL-no: 12.169], which is considered to be supporting for 
[FL-no: 12.241]. Althoug the available data are limited the Panel considered that for the remaining 19 
substances in FGE.74Rev3 the genotoxicity data do not preclude evaluating these substances through 
the Procedure. 
The Panel agrees with the application of the Procedure as performed by the JECFA for five of the 19 
aliphatic sulphides and thiols [FL-no: 12.238, 12.239, 12.255, 12.257 and 12.291]. For these five 
substances the Panel concluded, similar to the JECFA that these would not pose any safety concern at 
the current levels of exposure based on the MSDI approach. For three substances [FL-no: 12.179, 
12.198 and 12.212] the Panel reached the same conclusion, but used a NOAEL from a different study 
as the one used by the JECFA. 
For diallyl sulphide [FL-no: 12.088] the JECFA evaluated this substance at step B5 to be of no safety 
concern as the estimated intake in the USA is 0.4 µg/capita/day, which is below 1.5 µg/day. In line 
with the opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does not make 
use of this threshold of 1.5 µg per person per day. However, the Panel decided that this substance 
could be allocated to subgroup I, for which a supporting substance [FL-no: 12.006] provides a 
NOAEL. Based on the intake estimate (MSDI) for diallyl sulphide [FL-no: 12.088] and this NOAEL 
an adequate margin of safety of 4.3 x 106 could be calculated. 
For the two tertiary thiols [FL-no: 12.169 and 12.241] the Panel did not agree with the JECFA that 
appropriate studies were available for deriving NOAELs, and accordingly the Panel concluded that 
additional data are required for these two substances. 
For the eight tri- and polysulphides [FL-no: FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 12.074, 
12.155 and 12.280], the Panel concluded that the additional information submitted by the Industry was 
insufficient to evaluate the safety of the tri- and polysulphides. Therefore there is still a need for a 90-
day study for these substances. 
For one substance use levels have been provided by the Industry. The mTAMDI figure calculated for 
the substance [FL-no: 12.291] is below the threshold of concern for the structural class I. For the 
remaining 18 substances use levels must be provided. These are needed to calculate the mTAMDIs in 
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order to identify those flavouring substances that need more refined exposure assessment and to 
finalise the evaluation. 
In order to determine whether the conclusion for the JECFA evaluated substances can be applied to the 
materials of commerce, it is necessary to consider the available specifications. Specifications including 
purity criteria and identity are available for all the JECFA evaluated substances. 
Thus, for 10 candidate substances in FGE.74Rev3 [FL-no: 12.009, 12.013, 12.020, 12.023, 12.045, 
12.074, 12.155, 12.169, 12.241 and 12.280] evaluated through the Procedure, the Panel concluded that 
additional toxicity data are required.  
For the remaining nine JECFA evaluated simple aliphatic sulphides and thiols [FL-no: 12.088, 12.179, 
12.198, 12.212, 12.238, 12.239, 12.255, 12.257 and 12.291] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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SUMMARY OF GENOTOXICITY DATA  
Table 6:  Genotoxicity Data (in vitro / in vivo) evaluated by JECFA (JECFA, 2000; JECFA, 2004b) 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference Comments 
In vitro 
12.088 
458 
Diallyl sulfide S  Reverse mutation S. typhimurium TA100 
0.004 - 0.44 
µg/ml 
Negative(a) (Eder et 
al., 1982) 
The Panel noted that 
the publication by Eder 
et al., 1982a is not the 
correct paper to quote 
from. It has not been 
possible for EFSA to 
identify the correct 
paper.
12.291 
1289 
3-Mercapto-2-methyl-1-
butanol 
OH
SH
 
Reverse mutation S. typhimurium 
TA1535, TA97, 
TA98, TA100, 
TA102  
50 – 5000 µg/ 
plate  
Negative(a) (Gocke, 
1997)  
The racemate (Erythro- 
and threo-3-Mercapto-
2-methyl-1-butanol) 
was used in the 
toxicological 
evaluation. 
In vivo  
       
12.009 
587 
Diallyl trisulfide S
S
S
 In vivo mouse micronucleus test 
Mouse 0.33 – 0.67 
mM/kg (59 - 
120 mg/kg)(b) 
Negative (Marks et 
al., 1992) 
Insufficient quality. 
Mixture of three 
substances was tested. 
(a): With and without metabolic activation from S9. 
(b): Study used a mixture of allyl sulphide, allyl disulphide and allyl trisulphide in the respective ratio, 68:20:12. 
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Table 7:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012b) 
Chemical Name [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
 Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) Ames test  S. typhimurium TA100  0.004 – 0.44 µg/ml Negative  
(±S9) 
(Eder et al., 1982) Review. No details on 
method and results 
reported. Only TA100 
used. 
Sister chromatid 
exchange  
Chinese hamster ovary cells  200 - 600 µg/ml Positive(a) (Musk et al., 1997) Limited quality of study. 
Insufficiently reported.
Chromosomal 
aberrations  
Chinese hamster ovary cells  200 - 600 µg/ml Positive(a) (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Di-(1-propenyl)-sulfid 
(mixture) [12.298] 
Ames test S. typhimurium TA98, TA100, 
TA102, TA1535, TA1537 
1 – 100 µg/plate Negative(a) (Stien, 2005) Un-published GLP study. 
Study considered valid. 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene 
[15.102] 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537  
50 – 5000 µg/plate  Negative
(±S9)  
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Cytogenetic assay  Human lymphocytes  12.5 – 125 µg/ml  Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
HPRT assay  Chinese hamster ovary cells  100 – 200 µg/ml Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  15.63 – 125 µg/ml  Negative
(±S9)  
(Pennwalt 
Corporation, 1987b) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Unscheduled DNA 
synthesis  
Human epithelial cells  2.5 – 5120 µg/ml  Negative 
(±S9) 
(Pennwalt 
Corporation, 1987a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(1,4-Dithiane [15.066]) Ames test  S. typhimurium TA98, TA100  0.8 – 100 µ mol/plate (96.2 - 
12024 µg/plate)  
Positive   
(-S9) 
Negative  
(+S9)  
(Lee et al., 1994) Only two strains were 
tested, otherwise 
acceptable study. 
 Sister chromatid Chinese hamster ovary cells 2000 µM (240 µg/ml)  Negative (Lee et al., 1994) Insufficient quality.
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Table 7:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012b) 
Chemical Name [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
exchange  (±S9)   
Subgroup III – Monothiols 
2-Methylpropane-2-thiol 
[12.174] 
Ames test  
 
S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
10000 µg/plate  Negative 
(±S9)   
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Forward mutational 
MLTK assay  
L5178Y/tk+/- mouse lymphoma 
cells  
1000 µg/ml  Positive  
 (-S9) 
Negative 
(+S9) 
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  1350 µg/ml  Negative 
(+S9)(b) 
(Phillips Petroleum 
Company, 1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(Allyl mercaptan [12.004]) Modified Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538
0.005 – 1.5 µl/ml (4.6 – 1400 
µg/ml) 
Negative  
(±S9)  
(Eder et al., 1980) Acceptable quality. 
(Benzyl mercaptan [12.005]) Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
3.6 mg/plate (3600 µg/plate) Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(2-Mercaptopropionic acid 
[12.039]) 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative 
(±S9)   
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzenethiol [12.080]) Ames test S. typhimurium TA98, TA100 25 – 500 µg/plate  Negative  
(±S9) 
(LaVoie et al., 1979) Insufficient quality (only 
two strains were used, and 
all doses -except the 
lowest dose - were toxic). 
Subgroup IV – Dithiols 
(1,2-Ethanedithiol [12.066]) Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
5 doses up to 5000 µg/plate  Negative 
(±S9)   
(Phillips Petroleum 
Company, 1990b) 
Validity cannot be fully 
evaluated (only abstract 
provided). 
Sister chromatid 
exchange  
Chinese hamster ovary cells  0.5 - 50 µg/ml  Positive
(±S9)   
(Pence et al., 1982) Acceptable quality. 
Forward mutational 
assay   
L5178Y/tk+/- mouse lymphoma 
cells  
150 µg/ml  Positive   
(-S9)   
(Pence et al., 1982) Positive only at cytotoxic 
concentrations. 
Forward mutational L5178Y/tk+/- mouse lymphoma 1 µg/ml  Negative (Pence et al., 1982) Insufficiently 
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Table 7:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012b) 
Chemical Name [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
assay  cells  (+S9) documented. 
Subgroup V – Acyclic Di-, Tri-, and Poly-sulphides 
(Diallyl disulphide [12.008]) Modified Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538
0.0015 – 0.15 µg/ml  Negative  
(±S9)  
(Eder et al., 1980) Acceptable quality. 
Sister chromatid 
exchange  
Chinese hamster ovary cells  2 - 25 µg/ml  Weakly 
positive 
(±S9) 
(Musk et al., 1997) Limited quality. 
Insufficiently reported. 
Chromosomal 
aberrations  
Chinese hamster ovary cells  2 - 25 µg/ml  Positive
(±S9) 
(Musk et al., 1997) Limited quality. 
Insufficiently reported. 
(Dimethyl disulphide 
[12.026]) 
Ames test  S. typhimurium TA98, TA100, 
TA102  
0.000011 – 1.1 mmol/plate  
(1.04 - 104000 µg/plate) 
Negative  
(±S9)   
(Aeschbacher et al., 
1989) 
Limited quality (only 3 
strains used). 
(Phenyl disulphide [12.043]) Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9)   
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzyl disulphide [12.081]) 
 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
Dibutyl disulphide [12.111] Forward mutational 
assay  
Mouse lymphoma cells  NR  Negative  
(-S9)   
(Dooley et al., 1987) Validity cannot be fully 
evaluated (only abstract 
provided). 
Subgroup VIII – Thioesters 
(Methylthio 2-
(acetyloxy)propionate 
[12.203]) 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537,  
E. Coli WP2uvrA
0.156-5.0 mg/plate (156-5000 
μg/plate 
Negative  
(±S9) 
(Watanabe and 
Morimoto, 1989a) 
Acceptable quality. 
(Methylthio 2-
(propionyloxy) propionate 
[12.227]) 
Ames test  
 
S. typhimurium TA98, TA100, 
TA1535, TA1537,  
E. Coli WP2uvrA 
0.156 – 5.0 mg/plate (156 - 
5000 µg/plate)  
Negative
(±S9)   
(Watanabe and 
Morimoto, 1989b) 
Acceptable quality. 
Subgroup X – Sulfoxides/Sulphones and Sulphonates 
Methyl methane-
thiosulfonate [12.159] 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538, 
TA2637  
0.6 – 60 µg/plate  Negative
(-S9)   
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
Ames test  S. typhimurium TA98, TA100, 2 – 600 µg/plate  Negative  (Dorange et al., 1983) Test is not appropriate for 
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Table 7:  Genotoxicity Data (in vitro) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012b) 
Chemical Name [FL-no] 
 
Test system Test Object  Concentration Result  Reference  Comments 
TA1535, TA1537, TA1538, 
TA2637  
(+S9)  antimicrobial agents(f). 
Ames test  S. typhimurium TA98, TA100, 
TA2637 
0.6 – 60 µg/plate  Negative  
(-S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f).
Ames test  S. typhimurium TA98, TA100, 
TA2637  
0.6 – 200 µg/plate  Negative  
(+S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
Ames test  S. typhimurium TA98, TA100, 
TA2637  
NR Negative(c) (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
Ames test  S. typhimurium TA98, TA100, 
TA2637  
0.6 – 200 µg/plate  Negative(d) (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
Yeast assay  S. cerevisiae Strain D7 1– 300 µg/ml  Negative  
(±S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
Yeast assay 
 
S. cerevisiae Haploid strain 
N123  
1– 100 µg/ml  Negative  
(±S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents(f). 
(Methylsulfinyl methane 
[12.175]) 
(synonym: dimethylsulfoxid, 
DMSO) 
Ames test  S. typhimurium TA97, TA98, 
TA100  
100000 – 300000 µg/plate  Negative
(±S9) 
(Brams et al., 1987) Insufficient method (3 
strains and 3 
concentrations only). 
Ames test  S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537 
100 – 10000 µg/plate  Negative
(±S9)  
(Zeiger et al., 1992) Acceptable quality. 
Ames test  S. typhimurium TA97, TA98, 
TA100, TA102, TA104, 
TA1535, TA1538,  
E. Coli WP2  
0.1 – 0.4 ml/plate (100000 - 
400000 µg/plate)  
Negative   
(-S9) 
(Hakura et al., 1993) Good quality study. 
Ames test  S. typhimurium TA1537, 
TA2637,  
E. Coli WP2uvrA  
0.1 – 0.4 ml/plate (100000 - 
400000 µg/plate)  
Positive  
(-S9)(e)  
(Hakura et al., 1993) Good quality study. 
Positive at high doses with 
reduced bacterial survival. 
Doses routinely used in 
Ames test were negative. 
NR: Not reported. 
(a): With and without metabolic activation at clearly cytotoxic concentrations. 
(b): A statistically significant increase in the number of SCEs per chromosome was seen at 1350 µg/ml and the 450 µg/ml dose level in the presence of metabolic activation; but no significant 
increase was seen in the remaining dose levels, and no dose level showed a two fold increase in SCEs; therefore, t-butyl mercaptan is not considered to be mutagenic. 
(c): With 100 µl/plate fecalase. 
(d): With 100 µl/plate S9 metabolic activation and 100 µl/plate fecalase. Negative results reported after 2 days of incubation. Results for TA98 test strain were positive after 5 days of incubation 
(e):  Positive results obtained at doses where lethal toxicity was observed. Negative results obtained at doses routinely used in Ames test. 
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(f): Thiosulphonates in general, and methyl methane thiosulphonate in particular, are non-specific antimicrobial agents that are active at low concentrations on prokaryotic bacteria, as well as 
on yeast and other eukaryotic fungi. This was even pointed out by Dorange et al. (1983). Therefore bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity of 
thiosulphonates. 
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Table 8:  Genotoxicity Data (in vivo) EFSA / FGE.08Rev5 (EFSA CEF Panel, 2012b) 
Chemical Name [FL-no]  Test System Test Object Route Dose Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) In vivo mouse 
micronucleus test  
Mouse  Gavage 0.33 – 0.67 mM/kg 
(38 – 77 mg/kg)1 
Negative (Marks et al., 1992) Insufficient quality. Mixture of three 
substances was tested. 
Subgroup III – Monothiols  
(2-Mercaptopropionic acid 
[12.039]) 
In vivo Basc test  Drosophila  Dietary 
route 
10 mM  
(1061 µg/ml) 
Negative (Wild et al., 1983) Limited quality (insufficiently 
documented). The article compiles 
results obtained with 76 substances in 3 
test systems. 
Subgroup V – Acyclic and cyclic Disulphides 
(Allyl disulphide [12.008]) In vivo mouse micronucleus 
test  
Mouse Gavage 0.33 – 0.67 mM/kg  
(48 – 98 mg/kg) (a)  
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three 
substances was tested. 
Subgroup VI – Acyclic Tri- and Polysulphides 
(Diallyl trisulphide [12.009]) In vivo mouse 
micronucleus test  
Mouse  Gavage 0.33 – 0.67 mM/kg 
(59 - 120 mg/kg) (a) 
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three 
substances was tested. 
Subgroup X – Sulphoxides/Sulphones and Sulphonates 
Methyl methane-
thiosulfonate [12.159] 
In vivo genetic mutation Nicotiana 
tabacum 
seeds  
- 2 - 4 mg/ml  
(2000 - 4000 
µg/ml)  
Negative  (Dorange et al., 
1983) 
Obscure test system(b). This assay 
cannot be regarded as standard test. 
In vivo genetic mutation Nicotiana 
tabacum 
seeds 
- 50 – 400 µg/ml  Negative  (Dorange et al., 
1983) 
Obscure test system(b). This assay 
cannot be regarded as standard test. 
(a):  Study used a mixture of allyl sulphide, allyl disulphide and ally trisulphide in the respective ratio, 68:20:12. 
(b): Heterozygotic seeds were used. After exposure, the seeds were blotted on filter paper and planted in earthenware pots in medium normally used for planting tobacco. The leaves were 
analysed for alterations indicating genotoxicity. 
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Table 9:  Summary of Additional Genotoxicity Data on 2-methyl-4-oxopentane-2-thiol 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural 
formula 
End-point Test system Concentration Results Reference Comments 
12.169 2-Methyl-4-
oxopentane-2-thiol SH
O
 
Reverse 
mutation 
S. typhimurium 
TA98, TA100, 
TA1535, 
TA1537 and 
TA102 
5, 15. 81, 50, 158.1, 
500, 
1581 and 5000 
μg/plate(a) 
Negative (Mc Garry, 
2012) 
Valid GLP study, in compliance with 
OECD 471 Guideline 
156.3, 312.5, 625.0, 
1250, 
2500 and 5000 μg 
/plate(a,b) 
Negative  
(a): In the absence and presence of S9-mix metabolic bioactivation. 
(b): Assay modified with pre-incubation in presence of S9-mix. 
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SUMMARY OF SAFETY EVALUATIONS 
Table 10:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2004b) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on the 
named 
compound [(d) 
or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.013 
582 
Dimethyl trisulfide S
S
S
 1.1 0.02 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.020 
584 
Methyl propyl 
trisulfide 
S
SS
 0.21 0.1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.023 
585 
Dipropyl trisulfide S
S
S
 7.3 1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.155 
583 
Methyl ethyl trisulfide 
S
S S
 0.012 1 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists
d Toxicity data 
required. 
 
12.169 
1293 
2-Methyl-4-
oxopentane-2-thiol SH
O
 
0.69 
0.02 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.179 
1297 
2-(Methylthio)ethan-
1-ol 
HO
S
 0.97 0.9 
Class I 
B3: Intake below 
threshold 
d No safety concern at 
the estimated level of 
intake based on the 
No safety concern at 
the estimated level of 
intake based on the 
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Table 10:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2004b) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on the 
named 
compound [(d) 
or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
B4: Adequate 
NOAEL exists 
MSDI approach. MSDI approach. 
12.198 
1299 
2,3,5-Trithiahexane S S
S  0.024 0.04 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.212 
1298 
Ethyl-5-
(methylthio)valerate 
O
O S  
1.8 
2 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.238 
1291 
3-Mercapto-2-
methylpentan-1-ol OH
SH  
0.85 
0.7 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.239 
1292 
3-Mercapto-2-
methylpentanal 
O
HS  
2.6 
4 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.241 
1290 
2-Mercapto-2-
methylpentan-1-ol HO
SH
 
0.012 
4 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.255 
1294 
Ethyl 3-
mercaptobutyrate 
O
O SH  
3.4 
4 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
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Table 10:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2004b) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on the 
named 
compound [(d) 
or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
12.257 
1295 
Ethyl 4-(acetylthio)-
butyrate O
O
S
O
 
3.4 
4 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.280 
1300 
Diisopropyl 
trisulphide 
S
S
S  
0.24 
0.007 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.291 
1289 
3-Mercapto-2-methyl-
1-butanol 
OH
SH
 
0.061 
2 
Class I 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
12.009 
587 
Diallyl trisulfide S
S
S
 3.5 0.02 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.045 
586 
Methyl allyl trisulfide 
S
SS
 0.012 0.9 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.074 
588 
Diallyl polysulfides 
SX
X=2,3,4 or 5  
1.2 
0.02 
Class II 
B3: Intake below 
threshold 
B4: Adequate 
NOAEL exists 
d Toxicity data 
required. 
 
12.088 
458 
Diallyl sulfide S  3.5 0.4 
Class II 
B3: Intake below 
f No safety concern at 
the estimated level of 
No safety concern at 
the estimated level of 
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Table 10:  Summary of Safety Evaluation by the JECFA (JECFA, 2000; JECFA, 2004b) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI (a)  
US MSDI 
(μg/capita/day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on the 
named 
compound [(d) 
or (e)] 
EFSA conclusion on 
the named 
compound 
(Procedure steps, 
intake estimates, 
NOAEL, 
genotoxicity) 
EFSA conclusion on 
the material of 
commerce 
threshold 
B4: No adequate 
NOAEL 
B5: Intake below 1.5 
microg/person/day 
intake based on the 
MSDI approach. 
intake based on the 
MSDI approach. 
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 109 / (0.1 x population in Europe (= 375 x 106) x 0.6 x 365)  =  µg/capita/day. 
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): Cleared by JECFA as intake below 1.5 µg/person/day. 
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
0.3 
 
Class I 
B3: Intake below 
threshold, 
B4: Adequate 
NOAEL exists 
d f  
12.104 
 
Butane-2-thiol SH
 
0.18 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.106 
 
S-2-Butyl 3-
methylbutanethioate 
O
S
 
0.8 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.111 
 
Dibutyl disulfide 
S
S
 
0.37 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.112 
 
Dibutyl trisulfide 
S
S
S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.116 
 
Dimethyl tetrasulfide S
S
S
S
 
0.016 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.117 
 
Dipentyl sulfide S
 
0.0037 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.124 
 
Ethyl butyl sulfide S
 
0.037 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.125 
 
Ethyl propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.127 
 
Ethyl propyl sulfide S
 
0.085 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.129 
 
3-(Ethylthio)propan-1-
ol 
HO S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.135 
 
3-Mercapto-2-
methylpropionic acid 
HSHO
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.151 
 
Methyl butyl disulfide 
S
S
 
0.0061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.152 
 
Methyl butyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.158 
 
Methyl isoprenyl 
sulfide 
S
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.163 
 
Methyl prop-1-enyl 
sulfide 
S
 
0.0097 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.164 
 
Methyl prop-1-enyl 
trisulfide S
SS
 
0.0061 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.165 
 
S-Methyl 
propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.166 
 
Methyl propyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.167 
 
Methyl propyl 
tetrasulfide 
S
S
S
S
 
0.0037 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.178 
 
3-(Methylthio)butyric 
acid 
O
HO S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
B4: Adequate 
NOAEL exists 
12.180 
 
1-(Methylthio)ethane-
1-thiol 
SH
S
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.181 
 
1-(Methylthio)pentan-
3-one 
S
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.182 
 
2-
(Methylthio)propionic 
acid 
S
HO
O
 
0.011 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.183 
 
3-
(Methylthio)propionic 
acid SHO
O
 
0.21 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.189 
 
S-(Methylthiomethyl) 
2-methylpropanethioate 
S S
O
 
0.061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.191 
 
Pentane-1-thiol SH
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.196 
 
S-Prenyl 
thioisobutyrate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.199 
 
Ethanethioic acid 
HS
O
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.200 
 
1,1-bis(Ethylthio)-
ethane 
S S
 
0.0012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.205 
 
Mercaptoacetaldehyde 
SH
O
 
0.011 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.214 
 
Isobutyl-3-
(methylthio)butyrate 
S
O
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.221 
 
S-Prenyl 
thioisopentanoate 
S
O
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.250 
 
3-Mercaptohexanal O SH
 
0.012 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.266 
 
Methyl-2-
mercaptopropionate SH
O
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d h  
12.277 
 
3-(Methylthio)propyl 
butyrate 
O S
O
 
6.1 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.278 
 
3-Acetyl-
mercaptohexyl acetate 
O
O
S
O 1.2 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.282 
 
(S)-Methyl 
octanethioate 
O
S
 
0.24 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d g  
12.298 
 
Di-(1-propenyl)-sulfid 
(mixture) 
S
S
S
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.299 
 
3-(Methylthio)propyl 
hexanoate 
SO
O
 
0.061 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.303 
 
3-Pentanethiol SH
 
0.03 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.306 
 
3-(Methylthio)-decanal 
S
O
 
0.12 
 
Class I 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.304 
 
Ethyl-2-mercapto-2-
methyl propanoate 
O
O
SH
0.012 
 
Class I 
No evaluation 
  Pending update, as new 
genotoxicity data have 
become available. 
12.172 
 
2-Methylbutane-2-thiol 
HS
 
0.15 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.174 
 
2-Methylpropane-2-
thiol 
SH
 
0.0012 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.268 
 
3-Mercaptooctanal SHO
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012).  
12.269 
 
3-Mercaptodecanal SHO
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.271 
 
Methanedithiol 
diacetate 
S S
O O
 
 
 
Class I 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
NOAEL 
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.096 
 
Allyl methyl sulfide S
 
0.99 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.097 
 
Allyl methyl 
tetrasulfide S
S
S
S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.098 
 
Allyl prop-1-enyl 
disulfide S
S
 
0.17 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.099 
 
Allyl propyl sulfide S
 
1.6 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.100 
 
Allyl propyl trisulfide S
S
S
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.177 
 
8-(Methylthio)-p-
menthan-3-one 
O
S
 
0.37 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.302 
 
2-Butanol, 4-mercapto-
3-methyl SH
OH
 
0.061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.305 
 
2-Mercapto-4-heptanol SHOH
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.047 
 
3,5-Di-isobutyl-1,2,4-
trithiolane 
SS
S
 
0.024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.048 
 
3,5-Di-isopropyl-1,2,4-
trithiolane 
SS
S
 
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.056 
 
3,6-Dimethyl-1,2,4,5-
tetrathiane 
SS
S S
 
0.0024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f   
15.083 
 
3-Methyl-1,2,4-
trithiolane 
SS
S
 
0.0024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
15.102 
 
Tetrahydrothiophene S
 
0.024 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
  
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S
 
0.073 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.110 
 
2,4,6-Trimethyl-1,3,5-
trithiane 
S
S S
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.111 
 
1,2,4-Trithiolane 
S
S S
 
2.4 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.125 
 
4-
Tetrahydrothiopyranon
e 
S
O
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
12.295 
 
3,5-Dimethyl-1,2-
dithiolane-4-one 
S S
O
 
 
Class II 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
16.057 
 
2,4,4-Trimethyl-1,3-
oxathiane 
O
S
0.0012 
 
Class II 
No evaluation 
  Substance no longer 
supported by Industry 
(DG SANCO, 2012). 
Flavouring Group Evaluation 74 Revision 3
 
EFSA Journal 2014;12(6):3710 52
Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
12.120 
 
2,8-Epithio-p-menthane 
S
 
3.7 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data 
required 
 No longer supported by 
Industry (DG SANCO, 
2013). 
12.136 
 
3-Mercapto-2-
oxopropionic acid 
HSHO
O
O
 
0.24 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.300 
 
1,1-Propanedithiol SH
SH
 
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.301 
 
Methyl-2-oxo-propyl 
disulfide S
S
O
 
0.061 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.007 
 
Spiro(2,4-dithia-1-
methyl-8-
oxabicyclo[3.3.0]octane
-3,3'-(1'-oxa-2'-methyl)-
cyclopentane) and 
Spiro(2,4-dithia-6-
methyl-7-
oxabicyclo[3.3.0]octane
-3,3'-(1'-oxa-2'-methyl)-
cyclopentane) 
O
S
S
O
O
S
S
O
I
II
6.1 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
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Table 11:  Summary of Safety Evaluation by the EFSA (FGE.08Rev5) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI (a) 
(μg/capita/
day) 
Class (b) 
Evaluation 
procedure path (c) 
Outcome on 
the named 
compound [(d) 
or (e)] 
Outcome on the 
material of 
commerce [(f) , 
(g) or (h)] 
Evaluation remarks 
15.081 
 
Lenthionine S S
S S
S
 
0.012 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
15.134 
 
2,5-Dihydroxy-1,4-
dithiane 
S
S
HO
OH
 
6.1 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.062 
 
trans-2-Methyl-4-
propyl-1,3-oxathiane 
S
O
 
1.0 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.114 
 
2-Pentyl-4-propyl-1,3-
oxathiane 
S
O
 
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
16.122 
 
4-Methyl, 2-propyl, 1-
3-oxathiane 
S
O
 
0.24 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
d f  
12.159 
 
Methyl 
methanethiosulfonate S
O
O
S
 
0.061 
 
Class III 
No evaluation 
  No longer supported by 
Industry (DG SANCO, 
2013). 
a): EU MSDI: Amount added to food as flavour in (kg / year) x 109 / (0.1 x population in Europe (= 375 x 106) x 0.6 x 365)  = µg/capita/day. 
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): No safety concern at the estimated level of intake of the material of commerce meeting the specification requirement (based on intake calculated by the MSDI approach). 
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(g): Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or 
information on stereoisomerism. 
(h): No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ABBREVIATIONS 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good laboratory practice 
HPRT  Hypoxanthine Phosphoribosyl transferase 
ID  Identity 
IP  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  Micronucleated Binucleate cells 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
NMR  Nuclear Magnetic Resonance 
No  Number 
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NOAEL No Observed Adverse Effect Level 
NTP  National Toxicology Program 
OECD  Organization for Economic Cooperation and Development  
PCE  Polychromatic erythrocyte 
RI  Replication Index 
SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
UDS  Unscheduled DNA Synthesis 
WHO  World Health Organisation 
